SenesTech Inc. Raises $4.4 Million Through Warrant Exercise; Announces New Private Placement Warrants

Reuters
07/01
SenesTech Inc. Raises $4.4 Million Through Warrant Exercise; Announces New Private Placement Warrants

SenesTech Inc., a leader in fertility control for managing animal pest populations, has announced definitive agreements for the exercise of certain outstanding warrants to purchase a total of 1,458,872 shares of the company's common stock. Originally issued on March 11, 2025, these warrants have an exercise price of $2.90 per share. The transaction is expected to close around July 1, 2025, contingent on customary closing conditions. H.C. Wainwright is acting as the exclusive placement agent for this transaction. As part of the deal, SenesTech will issue new unregistered short-term warrants for up to 1,458,872 shares at an exercise price of $4.15 per share, with a purchase price of $0.125 per warrant in a private placement. These new warrants will be immediately exercisable and expire fifteen months after the effective date of the resale registration statement. The company anticipates gross proceeds of approximately $4.4 million from the existing warrant exercise, before fees and expenses, and potential gross proceeds of $6.0 million if the new warrants are fully exercised. The net proceeds will be used for working capital and general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SenesTech Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA21909) on July 01, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10